ITMCTR1900002602RecruitingPhase 4
Clinical efficacy of Xuefu Zhuyu Capsule combined with clopidogrel in the treatment of coronary heart disease after PCI for one year
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •(1) Coronary angiography showed that at least one coronary artery stenosis was more than 50%, but less than 75%. For those who did not receive PCI or received PCI, the indications of PCI were in accordance with the Chinese Medical Association Guidelines for Percutaneous Coronary Intervention (2016). Binary antiplatelet therapy was standardized after 1 year.
- •(2) Subjects were informed and voluntarily signed the informed consent.
- •(Note: Only those who meet the requirements of the above two items can be enrolled in the group.)
Exclusion Criteria
- •(1) Anti-platelet drug allergy or intolerance;
- •(2) Having hematological diseases or malignant tumors;
- •(3) There are active peptic ulcer and major surgical operations recently.
- •(4) Severe heart failure, severe liver and kidney dysfunction;
- •(5) History of stroke in the past;
- •(6) Severe cardiovascular or hemorrhagic events occurred within 1 year after PCI.
- •(7) Patients unwilling to continue receiving antiplatelet therapy after 12 months of dual antiplatelet therapy;
- •(8) those who are known to be allergic to the ingredients of the drug;
- •(9) Mental and neurological disorders;
- •(10) A similar experiment of traditional Chinese medicine has been done in the past three months.
- •(Note: The same subject can not be re-entered into the same clinical trial, and those who meet any of the above criteria can not be included)
Investigators
Similar Trials
Not yet recruiting
Phase 4
Clinical study of Xuefu Zhuyu Capsule in the treatment of acute chest pain after thoracoscopic surgery for early non-small cell lung cancerSCLCITMCTR2200005757Peking University People's Hospital
Not yet recruiting
Phase 1
Efficacy and safety of Xuefu Zhuyu Granules combined with Western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trialTCTR20220906002Dong Liu52
Recruiting
Phase 1
A clinical study on the efficacy of Xuefu Zhuyu Decoction in acute radiation esophagitis in esophageal cancer radiotherapyITMCTR2100004685Affiliated Hospital of Nanjing University of Chinese Medicine
Not yet recruiting
Phase 1
Clinical study of Shenyuan Yiqi Huoxue Capsule on cardiopulmonary motor function and quality of life in patients with Ischemic CardiomyopathyIschemic cardiomyopathyITMCTR2200006813Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Not yet recruiting
Phase 4
Clinical Study for Xuefu Zhuyu Capsule on Chest Pain after Thoracic Pneumonectomy in Early Stage Non-small Cell Lung Canceron-small cell lung cancerITMCTR1900002480Peking University People's Hospital